Stock EVAX EVAXION BIOTECH A/S
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Evaxion Biotech A/S

Equities

EVAX

US29970R2040

Delayed Nasdaq
Other stock markets
 11:31:13 29/04/2024 pm IST 		5-day change 1st Jan Change
4.13 USD -1.20% Intraday chart for Evaxion Biotech A/S -1.43% -39.77%
05:27pm European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading MT
26/04 European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4% MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ladenburg Thalmann Upgrades Evaxion Biotech to Buy From Neutral, Price Target is $8
MT
HC Wainwright Initiates Evaxion Biotech With Buy Rating, Price Target is $14
MT
European Equities Close Higher in Wednesday Trading; Eurozone Business Activity Falls at Slowest Rate in 6 Months
MT
Ladenburg Thalmann Downgrades Evaxion Biotech to Neutral From Buy
MT
US Equity Markets End Lower Wednesday as Central Bank Keeps Interest Rate Steady
MT
Lake Street Cuts Price Target on Evaxion Biotech to $7 From $18, Maintains Buy Rating
MT
Oppenheimer Adjusts Evaxion Biotech Price Target to $11 From $16, Maintains Outperform Rating
MT
Wall Street Set to Open Higher as Investors Brace for 75 Basis Point Rate Increase
MT
EVAXION BIOTECH A/S : Lake Street Starts Evaxion Biotech at Buy With $21 Price Target
MT
EVAXION BIOTECH A/S : Oppenheimer Initiates Coverage on Evaxion Biotech With Outperform Rating, $18 Price Target
MT
EVAXION BIOTECH A/S : Ladenburg Starts Evaxion Biotech at Buy with $23 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EVAX Stock
  4. News Evaxion Biotech A/S
  5. Analyst Reco.